SynDRA canonical compound SYN0000315 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Primary target(s) | RRM2 |
| Mechanism of action | Ribonucleoside reductase inhibitor |
| Indication | chronic myeloid leukemia (CML) | head and neck squamous cell carcinoma (HNSCC) |
| Disease area | hematologic malignancy | oncology |